• Insilico Medicine: A Leader in AI-driven Pharma Innovation

  • Apr 11 2024
  • Duración: 30 m
  • Podcast

Insilico Medicine: A Leader in AI-driven Pharma Innovation

  • Resumen

  • Insilico Medicine uses generative AI for drug discovery and has set the trend for AI in the pharmaceutical industry. They have developed an AI platform to identify novel targets and molecules, significantly reducing the time and cost of the drug discovery process. The company has a pipeline of novel molecules and drugs, with one asset in clinical trials for idiopathic pulmonary fibrosis (IPF). They’ve gained the trust of the pharma industry and have partnerships with big pharma and contract research organizations.

    Story Notes:

    • Introduction and Background of Insilico Medicine
    • Understanding Generative AI
    • Insilico Medicine's Approach to Drug Discovery
    • The Visionary Leadership of Alex Zhavoronkov


    To learn more, visit:
    https://boldcapitalpartners.com/

    Más Menos

Lo que los oyentes dicen sobre Insilico Medicine: A Leader in AI-driven Pharma Innovation

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.